3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
8
Gastrointestinal
4
Lymphoid
3
Genitourinary
2
Thoracic
1
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Dermatologic
1
Classical hematology
1
Breast
1
Conditions
Precancerous Conditions
20
Neoplasms
9
Advanced Malignant Neoplasm
9
Keratosis, Actinic
8
Skin Diseases
5
Keratosis
5
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
2
Preleukemia
2
Pathologic Processes
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hormone Receptor Positive Malignant Neoplasm of Breast
2
Hematologic Diseases
2
Endometrial Neoplasms
2
Carcinoma
2
Breast Neoplasms
2
Bone Marrow Diseases
2
Biochemical Recurrence of Malignant Neoplasm of Prostate
2
Uterine Prolapse
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Thrombocythemia, Essential
1
Syndrome
1
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Endometriosis
×
Other neoplasm
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled